EICHOR
● Active Not Recruiting
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis · Sponsor: AbbVie
About this study
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. The purpose of this study is to evaluate the clinical efficacy and safety of single therapies and/or combination therapies for moderate to severe AD through multiple substudies. This study will consist of multiple substudies. Substudy 1 will have a randomized, open-label period 1 followed by a lutikizumab treatment period 2 enrolling 80 participants at a 1 to 1 ratio. In Substudy 1, participants will receive subcutaneous (SC) injections of lutikizumab or matching placebo every other week for 16 weeks followed by an additional 32 weeks of SC injections of lutikizumab every other week for a total of 52 weeks. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic and may require frequent medical assessments, blood tests, and biomarker collections.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (30)
| Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550 | Fountain Hills, Arizona, United States | — |
| Dermatology Research Associates - Los Angeles /ID# 272945 | Los Angeles, California, United States | — |
| Integrative Skin Science and Research /ID# 274243 | Sacramento, California, United States | — |
| Clinical Trials Research Institute /ID# 274234 | Thousand Oaks, California, United States | — |
| Western States Clinical Res /ID# 271748 | Wheat Ridge, Colorado, United States | — |
| Skin Care Research Boca Raton /ID# 272544 | Boca Raton, Florida, United States | — |
| Research Associates of South Florida /ID# 272549 | Miami, Florida, United States | — |
| Advanced Clinical Research Institute - Tampa /ID# 272558 | Tampa, Florida, United States | — |
| Encore Medical Research - Weston /ID# 272539 | Weston, Florida, United States | — |
| Arlington Dermatology /ID# 271735 | Rolling Meadows, Illinois, United States | — |
| Somnos Clinical Research /ID# 272943 | Lincoln, Nebraska, United States | — |
| Equity Medical, LLC /ID# 272555 | New York, New York, United States | — |
+ 18 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06718101